Archive for December 2017

AAHP Shares FDA’s Commitment to Protecting Public Health

December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers the following statement: The American Association of Homeopathic Pharmacists (AAHP) shares the FDA’s commitment to protecting public health and applauds readm more…

Read More

Arnica montana: A Clinical Snapshot

By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known as Wolf’s bane or Leopard’s bane, this herb is found in high mountain pastures throughout Europe. The herb is extremely toxic when ingested due to readm more…

Read More

2017 Year in Review

2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a full plate. But together with our members, we made great strides in protecting our industry and bettering our businesses. Together, we: Developed a label disclaimer readm more…

Read More

Steps Toward Building Grassroots Support

December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional leaders in Washington and works with both agencies, your association is also working to mobilize stakeholders. It’s important for legislators readm more…

Read More